UnitedHealth Group Inc (UNH) Shares Bought by S. R. Schill & Associates

S. R. Schill & Associates lifted its holdings in UnitedHealth Group Inc (NYSE:UNH) by 9.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,813 shares of the healthcare conglomerate’s stock after buying an additional 330 shares during the quarter. S. R. Schill & Associates’ holdings in UnitedHealth Group were worth $747,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. Harbour Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 18,383.4% in the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after buying an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC raised its holdings in shares of UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after buying an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares during the last quarter. Parametric Portfolio Associates LLC raised its holdings in shares of UnitedHealth Group by 77.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after buying an additional 1,562,661 shares during the last quarter. Finally, Jennison Associates LLC raised its holdings in shares of UnitedHealth Group by 180.4% in the second quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after buying an additional 1,449,130 shares during the last quarter. 86.01% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Inc (NYSE UNH) opened at $228.73 on Friday. The stock has a market capitalization of $221,150.00, a PE ratio of 25.99, a PEG ratio of 1.53 and a beta of 0.66. UnitedHealth Group Inc has a 12-month low of $156.09 and a 12-month high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.17 EPS. equities research analysts predict that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.31%. UnitedHealth Group’s payout ratio is currently 34.09%.

In related news, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock valued at $7,669,416 over the last 90 days. Corporate insiders own 0.89% of the company’s stock.

A number of research analysts recently issued reports on the company. Wells Fargo & Co reaffirmed an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Citigroup boosted their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a report on Wednesday, October 18th. BMO Capital Markets initiated coverage on UnitedHealth Group in a report on Monday, October 16th. They set an “outperform” rating and a $250.00 price objective for the company. Finally, Jefferies Group reissued a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a report on Friday, December 1st. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $226.74.

WARNING: “UnitedHealth Group Inc (UNH) Shares Bought by S. R. Schill & Associates” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.com-unik.info/2018/01/06/unitedhealth-group-inc-unh-shares-bought-by-s-r-schill-associates.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit